Merck to expand Cali viral and gene therapy plant

By Gareth Macdonald contact

- Last updated on GMT

Merck's former Sigma-Aldrich facility in Carlsbad, California
Merck's former Sigma-Aldrich facility in Carlsbad, California
Germany's Merck has announced its intention to expand its viral and gene therapy production facility in Carlsbad, California.

The firm cited customer demand as the main driver for the investment, explaining that the plan was to add 21,000 square feet of production space, two fill/finish suites and clean rooms.

The expansion – which Merck said will increase current capacity by 90% - is due to be completed this year will support clinical and commercial production.

Merck said the expanded facility will work with both its cell-banking operations in Rockville, Maryland and its viral and gene therapy production capacity in Glasgow, Scotland.

The Carlsbad facility became part of Merck's manufacturing network through the acquisition of Sigma-Aldrich in 2014​.

News of the expansion follows just days after Merck announced it had upped bioreactor capacity at its facility in Martillac, France in a move designed to broaden its biologics manufacturing offering.

Related news

Show more

Related products

show more

Protect your bulk filtration and dispense step

Protect your bulk filtration and dispense step

Parker Bioscience Filtration | 20-Jan-2020 | Data Sheet

Does your process need greater protection when the value of your product is at its highest?

At the bulk filtration and container fill stage,...

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Downstream Purification of Large Biomolecules

Downstream Purification of Large Biomolecules

Bio-Rad Laboratories | 17-Sep-2018 | Research Study

Our newest strong anion exchange resin provides both high binding capacity and
high recovery, even at high flow rates. A rigid bead complete with...

CadenceILC_610x343

Inline concentration improves process economics

Pall Biotech | 15-Jun-2018 | Case Study

Would you like to enhance your downstream process, increase production capacity and reduce costs? This case study application note demonstrates how implementing...

Related suppliers

Follow us

Products

View more

Webinars